To assess whether a "virtual admission" can be useful for Parkinson's disease patients with severe motor fluctuations

Neurol Sci. 2021 Jun;42(6):2543-2545. doi: 10.1007/s10072-020-04939-9. Epub 2021 Jan 7.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiparkinson Agents
  • Humans
  • Levodopa
  • Parkinson Disease* / complications

Substances

  • Antiparkinson Agents
  • Levodopa